Address
Email address
Phone number
Website
https://www.biopark.eeHome - BioParkTartu Biotechnology Park provides infrastructural, business development and consultancy services to companies and R&D institutions.
Name
aktsiaselts Biotehnoloogia Park Kinnisvara
Registry code
10834232
VAT number
EE100736533
Type
AS - Joint Stock Company
Status
Registered
Foundation date
07.01.2002 (22)
Financial year
01.01-31.12
Capital
148 248.00 €
Activity
68201 - Rental and operating of own or leased real estate
399 594 €
48 268 €
12%
789 €
(estimate is approximate)
2 236 602 €
1
Submitted
No tax arrears
2%
2%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Global HR Partner OÜ 11808343 | 50% - 74 124.00 EUR | - | - | Shareholder |
| OÜ KALTEC 10804159 | 50% - 74 124.00 EUR | - | - | FounderShareholder |
| Andrus Tasa 10.01.1966 (58) | - | Board member | Direct ownership | |
| Jaanus Pikani 29.12.1959 (64) | - | - | Direct ownership | Board member |
| Laila Tasa 10.09.1968 (56) | - | - | - | Board member |
| Olev Matt 29.11.1964 (59) | - | - | - | Board member |
| Icosagen AS 10565884 | - | - | - | Founder |
| OSAÜHING IMMUNOTRON 10697203 | - | - | - | Founder |
| aktsiaselts EGeen 10766766 | - | - | - | Founder |
| Sihtasutus Tartu Teaduspark 90001121 | - | - | - | Founder |
| Sihtasutus Geenikeskus 90001569 | - | - | - | Founder |
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Celvia CC AS 11673707 | - | - | - | Founder |
| Sihtasutus Inicio 90011378 | - | - | - | Founder |
| osaühing TBD Pharmatech 11204964 | - | - | - | Founder |
| 2019 17.07.2020 | 2020 22.03.2021 | 2021 30.03.2022 | 2022 26.03.2023 | 2023 26.04.2024 | |
|---|---|---|---|---|---|
| Total Revenue | 474 794 € | 348 679 € | 396 045 € | 473 399 € | 399 594 € |
| Net profit (loss) for the period | 298 807 € | 79 058 € | 39 € | 376 802 € | 48 268 € |
| Profit Margin | 63% | 23% | 0% | 80% | 12% |
| Current Assets | 182 002 € | 190 477 € | 156 368 € | 217 569 € | 100 783 € |
| Fixed Assets | 2 286 480 € | 2 283 340 € | 2 281 349 € | 2 515 535 € | 2 441 086 € |
| Total Assets | 2 468 482 € | 2 473 817 € | 2 437 717 € | 2 733 104 € | 2 541 869 € |
| Current Liabilities | 118 008 € | 111 670 € | 144 212 € | 464 770 € | 140 267 € |
| Non Current Liabilities | 538 039 € | 470 654 € | 401 973 € | 0 € | 165 000 € |
| Total Liabilities | 656 047 € | 582 324 € | 546 185 € | - | 305 267 € |
| Share Capital | 148 248 € | 148 248 € | 148 248 € | 148 248 € | 148 248 € |
| Equity | 1 812 435 € | 1 891 493 € | 1 891 532 € | 2 268 334 € | 2 236 602 € |
| Employees | 3 | 2 | 1 | 1 | 1 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | 116 898.3 € | 7 227.29 € | 1 321.92 € | 1 |
| 2023 Q4 | 96 623.19 € | 12 325.47 € | 1 321.92 € | 1 |
| 2023 Q3 | 84 417.08 € | 11 681.14 € | 1 321.92 € | 1 |
| 2023 Q2 | 96 744.22 € | 8 430.15 € | 1 321.92 € | 1 |
| 2023 Q1 | 129 223.74 € | 29 500.23 € | 660.96 € | 1 |
| 2022 Q4 | 119 005.06 € | 10 647.84 € | 660.96 € | 1 |
| 2022 Q3 | 108 590.76 € | 9 817.54 € | 660.96 € | 1 |
| 2022 Q2 | 117 508.06 € | 3 608.09 € | 660.96 € | 1 |
| 2022 Q1 | 138 759.66 € | 9 467.7 € | 660.96 € | 1 |
| 2021 Q4 | 118 421.11 € | 7 069.6 € | 660.96 € | 1 |
| 2021 Q3 | 85 283.66 € | 9 488.44 € | 660.96 € | 1 |
| 2021 Q2 | 79 985.15 € | 8 601.85 € | 660.96 € | 1 |
| 2021 Q1 | 89 624.08 € | 4 694.36 € | 660.96 € | 1 |
| 2020 Q4 | 85 511.02 € | 8 905.85 € | 660.96 € | 1 |
| 2020 Q3 | 84 471.23 € | 7 434.64 € | 660.96 € | 1 |
| 2020 Q2 | 88 540.47 € | 7 086.05 € | 1 514.21 € | 1 |
| 2020 Q1 | 91 856.12 € | 7 981.17 € | 1 484.61 € | 2 |
